Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Amortization of Deferred Charges: 2021-2022

Historic Amortization of Deferred Charges for GeneDx Holdings (WGS) over the last 2 years, with Dec 2022 value amounting to $518,000.

  • GeneDx Holdings' Amortization of Deferred Charges changed negligibly% to $130,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $518,000, marking a year-over-year increase of 14.35%. This contributed to the annual value of $518,000 for FY2022, which is 684.85% up from last year.
  • Latest data reveals that GeneDx Holdings reported Amortization of Deferred Charges of $518,000 as of FY2022, which was up 684.85% from $66,000 recorded in FY2021.
  • In the past 5 years, GeneDx Holdings' Amortization of Deferred Charges ranged from a high of $518,000 in FY2022 and a low of $66,000 during FY2021.
  • In the last 2 years, GeneDx Holdings' Amortization of Deferred Charges had a median value of $292,000 in 2021 and averaged $292,000.
  • Data for GeneDx Holdings' Amortization of Deferred Charges shows a peak YoY skyrocketed of 684.85% (in 2022) over the last 5 years.
  • Over the past 2 years, GeneDx Holdings' Amortization of Deferred Charges (Yearly) stood at $66,000 in 2021, then skyrocketed by 684.85% to $518,000 in 2022.